newsfilter
← Latest News
Business Wire·

Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today